Primerica, Inc. (PRI): what the price assumes
In the published model solve dated 2026-Q2, anchored at $320.08, Primerica, Inc. (PRI) is priced for 26.0% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.
Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/PRI
Headline
| Field | Value |
|---|---|
| Ticker | PRI |
| Company | Primerica, Inc. |
| Current price | $320.08/sh |
| Composition | Term Life Insurance 59% / Investment and Savings Products 41% |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | financials |
| Elite ROE must persist for | 14.2y before normalizing (held at the 23.2% elite tier) |
| Perpetuity-equivalent ROE | 26.0% |
| Return on equity now | 20.8% |
| ROE gap | +5.2pp |
| Price-to-book | 3.96x |
Solve inputs: computed at a 9.6% cost of equity; ROE searched up to the 23.2% ROE ceiling; each 1pp moves the implied horizon ~1.4 years.
How unusual the bet is: elevated
| Reference | Value |
|---|---|
| vs own history | +1.38σ |
| cohort percentile (of 88 peers) | 86 |
| sustained it ~10 years at this level | 46% |
| implied end-window share | 0% |
Valuation X-Ray
The price is supported by asset-based and earnings-power value. A value/asset-supported name, not a pure growth bet.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 1.22x | 3 | expensive |
| Earnings | 1.24x | 1 | expensive |
| Relative | — | 0 | — |
| Growth | — | 0 | — |
Families that justify the price: Asset, Earnings
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.0%); the inversion above states its own rate.
Per-Model Detail (n=4)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | — | — | no | — |
| Bank Fair Value (P/TBV) | — | $470.67 | 0.68x | yes | TBVPS $77.99 × 6.03x (ROE (TTM) 30.6% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption)) |
| Relative Valuation | Relative | — | — | no | P/E 11x (static sector reference · 2026-04), scenarios: 9.2x / 11.0x / 12.8x (bear / base = reference held flat / bull), EV/EBITDA 22x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $263.14 | 1.22x | yes | BV/sh $79.42, ROE (TTM) 30.6%, ke 9.3% |
| Two-Stage Excess Return | Asset | $496.32 | 0.64x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | — | — | no | Rev $3.4B, growth 6% (input: historical growth; tapered), Terminal P/S: 2.5x / 3.0x / 3.5x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | — | — | no | EPS $23.83, growth 2% (input: historical EPS growth), PEG=6.58 (Overvalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | — | — | no | — |
| Residual Income | Asset | — | — | no | — |
| Graham Number | Asset | $206.36 | 1.55x | yes | √(22.5 × EPS $23.83 × BVPS $79.42) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | — | — | no | — |
| FCF Yield | Earnings | — | — | no | — |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | — | — | no | EPS $23.83 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | — | — | no | — |
| PEG Fair Value | Relative | — | — | no | EPS $23.83 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x |
| Earnings Yield | Earnings | $257.62 | 1.24x | yes | EPS $23.83 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Economic-Unit Decomposition (Sum Of The Parts)
The issuer is a funded financial business. Debt, interest, and cash flows are operating inputs, so industrial EV, net-debt, WACC, and free-cash-flow lenses do not apply; value the common-equity claim with book, earnings, capital, and payout economics.
| Unit | Role | Valuation basis | Revenue | Reported profit | Value evidence | Status |
|---|---|---|---|---|---|---|
| Term Life Insurance | financial | equity | 1.8B reported-currency | — | withheld | unresolved standalone equity facts required |
| Investment and Savings Products | financial | equity | 1.2B reported-currency | — | withheld | unresolved standalone equity facts required |
No unit-level total common-equity value is stated. Each financial unit requires supported standalone common equity, normalized earnings, capital adequacy, and payout capacity. Consolidated debt, interest, and cash are operating balances, not an enterprise-to-equity bridge; company-level book, earnings, capital, and payout lenses remain the coherent cross-checks.
Solvency
| Field | Value |
|---|---|
| Share count CAGR (buyback) | -5.2% |
Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).
Bullet Takeaways
- Primerica sells term life insurance (about 59% of the business) and investment and savings products (41%) to middle-income households through a large independent sales force of roughly 150,000 licensed representatives. The distribution network, not the products, is the asset.
- Profitability is exceptional. The company has recently earned a return on equity around 20%, far above the cost of capital, which is why an insurer like this is read off price-to-book, not an earnings multiple. At about 3.5 times book the price prices in elite, sustained returns.
- Q1 2026 was strong, with record investment-product sales of $4.3 billion, up 22%, but recruiting fell 17% and the licensed sales force shrank 2%, the watch item for a distribution-driven model.
Bull Case
What a conventional valuation misses about Primerica is that its real asset does not sit on the balance sheet: it is a distribution machine. The company sells term life insurance and investment products to middle-income households almost entirely through a network of roughly 150,000 independent, life-licensed sales representatives who recruit and train the next generation themselves. The filing describes how this scales cheaply, noting that "by sharing training and compliance activities with RVPs, we are able to grow the Company without incurring proportionate overhead expenses" (FY2025 10-K). That is a capital-light, self-replicating distribution model that is extraordinarily hard for a competitor to copy, because the moat is a culture and a network, not a product.
The returns prove the model works. Primerica has recently been earning a return on equity around 20%, an elite level for a financial company, and it returns capital aggressively, shrinking its share count by roughly 5% a year through buybacks on top of a dividend. The first quarter of 2026 showed the engine running: total revenue rose 8% to $872.7 million, net income rose 12% to $190.1 million, and diluted adjusted operating EPS jumped 19% to $5.96. The investment and savings business is the growth standout, with record sales of $4.3 billion, up 22%, and client assets of $127 billion, up 15%, while term life delivered steady 4% premium growth at a 22.5% margin.
The valuation, read correctly, is reasonable for the quality. An insurer is worth the return it earns on its capital, so the price is read off price-to-book, and at about 3.5 times book Primerica is pricing in a continuation of its high return on equity. For a business compounding book value at a 20% return while buying back stock and serving a structurally underinsured middle market, paying book value plus a premium for that return stream is a defensible proposition.
Bear Case
The models disagree most where it matters, and the conservative ones are the more honest read on a name priced for perfection. At about 3.5 times book, Primerica's price-to-book sits at the very top of its peer group, and the price prices in a return on equity beyond the elite 17.4% tier sustained for decades. Historically only about half of firms earning this kind of return sustained it for even ten years. The earnings-power method already reads the price as full, and the price-to-tangible-book method places fair value below the quote, which means the market is paying up for a level of profitability that the base rate says is hard to maintain. When a high-quality financial trades at the top of its peer multiple, the bar for disappointment is low.
The structural vulnerability is the distribution model itself, which cuts both ways. The bull case is that the sales force is self-replicating; the bear case is that it can shrink just as organically. The filing is blunt that "our failure to continue to attract new recruits, retain independent sales representatives or license or maintain the licensing of independent sales representatives would materially adversely affect our business" (FY2025 10-K), and it notes "wide disparities in the productivity of individual independent sales representatives" (FY2025 10-K). The first quarter showed the warning signs: recruiting fell 17%, new life licenses fell 14%, and the licensed sales force shrank 2%. A distribution-driven company whose distribution is contracting is the precise risk the high multiple ignores.
The cyclicality and mix risk round it out. The investment and savings business, now a large and growing share of earnings, ties results to equity markets, so a market downturn would hit both asset values and sales just as it pressures the middle-income customer. Term life sales are guided flat to down, and management expects higher expense growth in 2026. If the sales force keeps shrinking, markets soften, and the return on equity normalizes off its peak, a price at the top of the peer range on a peak return has meaningful downside, and the buyback cannot fully offset a derating.
Valuation
Primerica is valued as a financial, so the price is read off price-to-book rather than an operating multiple, because an insurer is ultimately worth the return it earns on its capital. A reasonable-growth re-pricing produces a base near $240 with a range up toward $267, so the price sits at the upper end of that band.
Inverting the price into the assumption it embeds, the market is paying about 3.5 times book, which prices in a return on equity beyond the elite 17.4% tier sustained for a very long time. That is a bound, not a solved point: the company has recently been earning around 20%, so the assumed return is within reach of its own record, but the price-to-book is at the very top of the peer group, and historically only about half of firms earning this return sustained it for ten years. The read is that the price is reasonable if the high return persists and full if it normalizes.
The honest conclusion is that Primerica is a genuinely high-quality, high-return financial trading at a price that already credits that quality. The valuation is not stretched relative to the returns it earns, but it leaves little room for the return on equity to fade or the sales force to keep shrinking. The capital return, a buyback shrinking the count about 5% a year plus a dividend, supports per-share value. An investor is paying a premium-to-book price for a 20% return stream, which is fair only as long as the 20% holds.
Catalysts
The near-term catalysts split between the two businesses. The investment and savings segment is the growth engine, with record first-quarter 2026 sales of $4.3 billion, up 22%, and client assets of $127 billion, up 15%; management guides upper-single-digit ISP sales growth for the year. Term life is the steadier piece, with adjusted direct premiums up 4% at a 22.5% margin, though policies issued are guided flat to down about 2%. The balance between these two, and the trajectory of equity markets that drives the investment side, will shape quarterly results.
The sales force metrics are the leading indicator to watch. The first quarter showed recruiting down 17%, new life licenses down 14%, and the licensed sales force down 2% to 149,732, though management expects the licensed force to end 2026 flat to up about 1%. Because the whole model runs on this network, a return to recruiting and licensing growth would be the most important positive signal, and continued contraction the most important negative one.
Capital return and expenses are the supporting threads. Primerica continues to buy back stock, shrinking the share count meaningfully, and pays a growing dividend, while guiding 2026 operating expense growth of 7% to 8% with a heavier second quarter. Analyst sentiment is neutral, with a median price target around $300 to $308, modestly above the current price, reflecting respect for the quality balanced against the conservative recruiting and term-life outlook.
Sources:
- https://investors.primerica.com/news-events/press-releases/detail/376/primerica-reports-first-quarter-2026-results
- https://www.stocktitan.net/sec-filings/PRI/8-k-primerica-inc-reports-material-event-b36a98e33de0.html
- https://www.fool.com/earnings/call-transcripts/2026/06/01/primerica-pri-q1-2026-earnings-transcript/
- https://stockanalysis.com/stocks/pri/forecast/
- https://public.com/stocks/pri/forecast-price-target
Peer Cohorts (Per Segment, With Filing Citations)
Term Life Insurance (reported)
- GL (GLOBE LIFE INC.)
- FY2025 10-K: …collected during the reporting period for all policies in their first policy year. First-year collected premium takes lapses into account in the first year when lapses are more likely to occur, and thus is a useful indicator of how much new premium is expected to be added to premium income in the future. First-year…
- FY2025 10-K: …Method Underwriting Company Products and Target Markets Distribution Direct to Consumer Division Globe Life And Accident Insurance Company McKinney, Texas Individual life and supplemental health limited-benefit insurance including juvenile and senior life coverage and Medicare Supplement to lower middle-income to…
- PRU (PRUDENTIAL FINANCIAL INC)
- FY2025 10-K: …and expenses based on specific product features. While the majority of our premiums are derived from the National Market segment (over 5,000 benefit-eligible employees), we continue to diversify our book through growth of the Premier Market (between 100-5,000 benefit-eligible employees) and Association segments…
- FY2025 10-K: …Products The primary components of our material product types are described as follows: 7 Table of Contents Variable Life Permanent coverage for life with potential to accumulate policy cash value based on underlying investment options. • Variable life policies offer flexibility in payment options and the potential…
- MET (MetLife, Inc.)
- FY2025 10-K: . We distribute Group Benefits products and services through a sales force primarily comprised of MetLife employees that is segmented by the size of the target customer. Account executives sell either directly to corporate and other group customers or through an intermediary, such as a broker or consultant. Employers…
- FY2025 10-K: …party is still living. Variable Life Insurance Insurance coverage through a contract that gives the policyholder flexibility in investment choices and, depending on the product, in premium payments and coverage amounts, with certain guarantees. Premiums and account balances can be directed by the policyholder into a…
- LNC (LINCOLN NATIONAL CORPORATION)
- FY2025 10-K: Term and Lincoln LifeElements ® Level Term. Distribution The Life Insurance segment's products are sold through LFD. LFD provides the Life Insurance segment with access to financial intermediaries in the following primary distribution channels: wire/regional firms; independent planner firms; financial institutions;…
- FY2025 10-K: …life-contingent annuities and non-participating traditional life insurance contracts (i.e., term insurance). The reserve is the net of present value of expected future policy benefits less present value of expected net premiums as summarized in the following table (in millions, except years): As of or For the Year…
- JXN (Jackson Financial Inc.)
- FY2025 10-K: …Statements | 9. Reserves for Future Policy Benefits and Claims Payable For limited-payment insurance contracts, premiums are paid over a period shorter than the period over which benefits are provided. Gross premiums received in excess of the net premium are deferred and recognized as a deferred profit liability…
- FY2025 10-K: …insurance contracts are reported as revenues when due. Benefits, claims and expenses are associated with earned revenues in order to recognize profit over the lives of the contracts. This association is accomplished through provisions for future policy benefits and the deferral and amortization of certain acquisition…
- CRBG (Corebridge Financial, Inc.)
- FY2025 10-K: …are expected to continue to bring process improvements and cost efficiencies. Products We are focused on providing financial security for our policyholders and their beneficiaries when they need it most. Our life insurance and protection products include Term, IUL and Whole Life. Our product suite was historically…
- FY2025 10-K: …health. This underwriting methodology is typically paired with a graded death benefit product that limits death benefit proceeds during the first few years of a life insurance policy to minimize adverse mortality impacts and keep coverage affordable. SIWL underwriting requires limited applicant information relative…
- EQH (Equitable Holdings, Inc.)
- FY2025 10-K: …investment options. In the Separate Account investment options, the policyholder bears the entire risk and returns of the investment results. Whole Life ("WL") A life insurance policy that is guaranteed to remain in-force for the policyholder's lifetime, provided the required premiums are paid. 243 Table of Contents…
- FY2025 10-K: …be greater than the underlying AV. Guaranteed Universal Life A universal life insurance offering with a lifetime no lapse guarantee rider, otherwise known as a guaranteed UL policy. With a GUL policy, the premiums are guaranteed to last the life of the policy. Guaranteed withdrawal benefit for life ("GWBL") An…
- UNM (Unum Group)
- FY2025 10-K: …of Colonial Life segment premium income generated by each product line during 2025 is as follows: Accident, Sickness, and Disability 54.0 % Life 26.3 Cancer and Critical Illness 19.7 Total 100.0 % Accident, Sickness, and Disability The accident, sickness, and disability product line consists of short-term disability…
- FY2025 10-K: …a renewable term life insurance product and a group dependent life product. The renewable term life product provides a lump sum benefit to the beneficiary upon the death of an employee. The group dependent life product, which we discontinued offering to new customers in 2012, provides an annuity to the beneficiary…
Investment and Savings Products (reported)
- LPLA (LPL Financial Holdings Inc.)
- FY2025 10-K: …portion of our clearing deposit requirements at various clearing organizations, to track the performance of our research models and in connection with our dividend reinvestment program. Trading securities are included in investment securities while securities sold, but not yet purchased are included in other…
- FY2025 10-K: …planning, financial planning and asset management solutions. Please consult Part I, "Item 1. Business" for information related to our business activities. 39 Table of Contents Our Sources of Revenue Our revenue is derived primarily from fees and commissions from products and advisory services offered by our advisors…
- AMP (AMERIPRISE FINANCIAL INC)
- FY2025 10-K: …Income Banking and Deposit Interest Expense Distribution Expenses Interest Credited to Fixed Accounts Benefits, Claims, Losses and Settlement Expenses Change in Fair Value of Market Risk Benefits General and Administrative Expense (in millions) Year Ended December 31, 2025 Interest rate contracts $ ( 1 ) $ - $ - $ -…
- FY2025 10-K: …accumulate cash value that increases by a fixed interest rate. Purchasers of VUL can select from a variety of investment options and can elect to allocate a portion of their account balance to a fixed account or a separate account. A vast majority of the premiums received for VUL policies are held in separate…
- VOYA (Voya Financial, Inc.)
- FY2025 10-K: …of Investments and Derivatives Our investment portfolio includes certain investments recorded at fair value and consists of public and private fixed maturity securities, commercial mortgage and other loans, equity securities, short-term investments, other invested assets and derivative financial instruments. We enter…
- FY2025 10-K: …and comprehensive financial services to individual customers. The Investment Management segment provides investment products and retirement solutions across a broad range of geographies, market sectors, investment styles and capitalization spectrums. Products and services are offered to institutional clients,…
- BEN (FRANKLIN RESOURCES, INC.)
- FY2025 10-K: …classes. Our equity capabilities include value, deep value, core value, blend, growth and growth at a reasonable price, convertibles, sector, Shariah, smart beta and thematic investments. Our fixed income capabilities include government, municipals, corporate credit, bank loans, securitized, multi-sector, and other…
- FY2025 10-K: …and the products for which we provide sub-advisory services, are typically subject to various termination rights and/or renewal provisions, which often provide for termination upon relatively short notice with little or no penalty. Retail Separately Managed Account Programs Certain of our specialist investment…
- IVZ (Invesco Ltd.)
- FY2025 10-K: …commercial loans, income based products inclusive of private strategies, and seed capital in fixed income funds, the valuation of which could vary with changes in interest and default rates as well as credit quality deterioration. Declines in the values of AUM could lead to reduced revenues and net income as…
- FY2025 10-K: …and contingent losses. Additionally, estimation is involved when determining investment and debt valuation for certain CIP; however, changes in the fair values of these amounts are largely offset by noncontrolling interests. Use of available information and application of judgment are inherent in the formation of…
- TROW (PRICE T ROWE GROUP INC)
- FY2025 10-K: …seed capital investments 316.1 262.8 Investments used to hedge the deferred compensation liabilities 1,243.3 992.8 Investment partnerships and other investments 154.7 62.6 Investments in affiliated collateralized loan obligations 3.2 6.3 Equity method investments T. Rowe Price investment products Discretionary…
- FY2025 10-K: …Institutional investors U.S. Mutual Funds x x x x Collective Investment Trusts x x x Exchange-Traded Funds x x x College Savings Plans x x Model Portfolios x x x (6) Separately Managed Accounts (SMAs) (1) x x x Subadvised Accounts x x x x Separate Accounts x x x x x SICAVs (2) / FCPs (3) x x x Canadian Pooled Funds x…
- SEIC (SEI INVESTMENTS COMPANY)
- FY2025 10-K: …implementations. 82 Disaggregation of Revenue The following tables provide additional information pertaining to our revenues disaggregated by major product line and primary geographic market based on the location of the use of the products or services for each of the Company's business segments for 2025, 2024 and…
- FY2025 10-K: …of operations or financial condition. 27 Ending Asset Balances This table presents ending asset balances of our clients, or of our clients' customers, for which we provide management or administrative services through our subsidiaries and partnerships in which we have a significant interest. Ending Asset Balances (In…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.